These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548 [TBL] [Abstract][Full Text] [Related]
4. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium. Jia J; Davis CM; Zhang W; Edin ML; Jouihan S; Jia T; Bradbury JA; Graves JP; DeGraff LM; Lee CR; Ronnekleiv O; Wang R; Xu Y; Zeldin DC; Alkayed NJ Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice. Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948 [TBL] [Abstract][Full Text] [Related]
6. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. Xiao B; Li X; Yan J; Yu X; Yang G; Xiao X; Voltz JW; Zeldin DC; Wang DW J Pharmacol Exp Ther; 2010 Sep; 334(3):784-94. PubMed ID: 20501636 [TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice. Ma B; Xiong X; Chen C; Li H; Xu X; Li X; Li R; Chen G; Dackor RT; Zeldin DC; Wang DW Endocrinology; 2013 Aug; 154(8):2843-56. PubMed ID: 23696562 [TBL] [Abstract][Full Text] [Related]
9. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity. Muñoz M; López-Oliva E; Pinilla E; Rodríguez C; Martínez MP; Contreras C; Gómez A; Benedito S; Sáenz-Medina J; Rivera L; Prieto D Biochem Pharmacol; 2022 Jan; 195():114850. PubMed ID: 34822809 [TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Chen G; Wang P; Zhao G; Xu G; Gruzdev A; Zeldin DC; Wang DW Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):63-71. PubMed ID: 21742052 [TBL] [Abstract][Full Text] [Related]
11. CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. Abraham NG; Sodhi K; Silvis AM; Vanella L; Favero G; Rezzani R; Lee C; Zeldin DC; Schwartzman ML Hypertension; 2014 Dec; 64(6):1352-61. PubMed ID: 25245389 [TBL] [Abstract][Full Text] [Related]
12. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance. Yang Y; Dong R; Chen Z; Hu D; Fu M; Tang Y; Wang DW; Xu X; Tu L Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Yang B; Graham L; Dikalov S; Mason RP; Falck JR; Liao JK; Zeldin DC Mol Pharmacol; 2001 Aug; 60(2):310-20. PubMed ID: 11455018 [TBL] [Abstract][Full Text] [Related]
14. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
15. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. Shahabi P; Siest G; Visvikis-siest S Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964 [TBL] [Abstract][Full Text] [Related]
16. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease. Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404 [TBL] [Abstract][Full Text] [Related]
17. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy. Chen C; Wang DW Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135 [TBL] [Abstract][Full Text] [Related]
18. Roles of the epoxygenase CYP2J2 in the endothelium. Askari A; Thomson SJ; Edin ML; Zeldin DC; Bishop-Bailey D Prostaglandins Other Lipid Mediat; 2013 Dec; 107():56-63. PubMed ID: 23474289 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. Li R; Xu X; Chen C; Yu X; Edin ML; Degraff LM; Lee CR; Zeldin DC; Wang DW Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291 [TBL] [Abstract][Full Text] [Related]
20. Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. Oni-Orisan A; Deng Y; Schuck RN; Theken KN; Edin ML; Lih FB; Molnar K; DeGraff L; Tomer KB; Zeldin DC; Lee CR Prostaglandins Other Lipid Mediat; 2013; 104-105():67-73. PubMed ID: 23000418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]